6
KLBF0309.TXT

KLBF
Kalbe Farma Tbk
Af          :
Sector Code : 53
Sector Name : PHARMACEUTICALS

(In thousand rupiah except Par Value, Closing Price and Ratios)

Financial Statement Date    : 30-Sep-2003
Fiscal Year Ends            : Dec
Months Covered in Income St : 9

Summary of Balance Sheet
  Receivables               :     536,672,566.02
  Inventories               :     318,281,728.15
  Current Assets            :   1,692,677,337.04
  Fixed Assets              :     494,503,759.38
  Other Asstes              :       7,919,817.12
  Total Assets              :   2,381,684,820.31
  Current Liabilities       :   1,160,233,918.26
  Longterm Liabiities       :     253,178,618.19
  Total Liabilities         :   1,413,412,536.44
  Authorized                :       8,500,000.00
  Paid-up Capital           :     406,080,000.00
  Par Value                 :                100
  Paid-up Capital Shares    :       4,060,800.00
  Retained Earnings         :     336,772,517.18
  Total Equity              :     765,930,470.48
  Minority Interest         :     202,341,813.38

Summary of Income Statement
  Total Sales               :   2,167,892,314.09
  Cost of Good Sold         :     980,281,940.65
  Gross Profit              :   1,187,610,373.44
  Operating Profit          :     480,910,812.10
  Other Income              :       3,897,710.23
  Eearning Before Tax       :     484,808,522.33
  Tax                       :     161,597,178.59
  Net Income                :     279,481,187.93
  Closing Price             :             625.00

Per Share Data (Rp)
  Eps                       :              91.77
  Book Value                :             188.62

Financial Ratios
  Debt Equity Ratio (X)     :               1.85
  Roa (%)                   :              15.65
  Roe (%)                   :              48.65
  Npm (%)                   :              17.19
  Opm (%)                   :              29.58

Cash Flow
  CF from Operating Activities                        :     335,213,756.57
  CF from Investing Activities                        :    -396,317,619.77
  CF from Financing Activities                        :       3,620,107.38
  Net Increase in Cash & Cash Equivalent              :     -57,597,333.64
  Cash & Cash Equivalent at The Beginning of The Year :     428,444,489.55
  Cash & Cash Equivalent at The End of The Year       :     370,847,155.91

 
 
 
